Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
-
221
-
222
-
223
GWAS analysis identifies several single nucleotide polymorphisms (SNPs) that are associated with the changes in viral copies.
Published 2024“…(C) The corresponding synonymous (triangles) and non-synonymous (circles) amino acid changes that associate with increased or decreased viral copies. …”
-
224
GWAS analysis identifies several single nucleotide polymorphisms (SNPs) that are associated with the changes in viral copies.
Published 2024“…(C) The corresponding synonymous (triangles) and non-synonymous (circles) amino acid changes that associate with increased or decreased viral copies. …”
-
225
-
226
-
227
-
228
-
229
-
230
-
231
-
232
-
233
-
234
Adverse event list.
Published 2025“…Some patients reported mild dizziness for a few hours after TLN following many but not all administrations throughout the study.</p><p>Non-motor symptoms of PD, motor parkinsonian signs off medication, and quality of life improved significantly during the treatment phase, including the MDS-UPDRS total score (mean decrease −11.09; 95% Confidence Interval [CI]; −18, −4.1; <i>p</i> = 0.006), the Parkinson’s disease Questionnaire-39 (PDQ-39) summary index (mean decrease −2.91; 95% CI; −4.4, −1.4; <i>p</i> = 0.005), and the Non-Motor Symptoms Questionnaire (NMS-Quest) (mean decrease −4.27; 95% CI; −6.5, −2.1; <i>p</i> = 0.009). …”
-
235
Patient characteristics.
Published 2025“…Some patients reported mild dizziness for a few hours after TLN following many but not all administrations throughout the study.</p><p>Non-motor symptoms of PD, motor parkinsonian signs off medication, and quality of life improved significantly during the treatment phase, including the MDS-UPDRS total score (mean decrease −11.09; 95% Confidence Interval [CI]; −18, −4.1; <i>p</i> = 0.006), the Parkinson’s disease Questionnaire-39 (PDQ-39) summary index (mean decrease −2.91; 95% CI; −4.4, −1.4; <i>p</i> = 0.005), and the Non-Motor Symptoms Questionnaire (NMS-Quest) (mean decrease −4.27; 95% CI; −6.5, −2.1; <i>p</i> = 0.009). …”
-
236
Table 1_Glucose and lipid metabolism in non-diabetic, non-obese patients with obstructive sleep apnea: sex differences.docx
Published 2025“…The high-density lipoprotein cholesterol (HDL-C) level in OSA participants was significantly lower (0.99 vs. 1.12 mmol/L, p = 0.036), and the triglyceride-glucose (TyG) index was significantly higher (8.74 vs. 8.45, p = 0.016), while there was no significant difference in the levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and non-HDL-C. …”
-
237
Multiple comparisons after ANOVA(CR10).
Published 2025“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
-
238
Homogeneity test of CR10.
Published 2025“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
-
239
Illustration of the fNIRS device worn.
Published 2025“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
-
240
Analysis of variance of HbO<sub>2</sub> in bilateral PFC.
Published 2025“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”